U.K. PCR-Based Transplant Diagnostics Market to 2032

Overview

The U.K. PCR-Based Transplant Diagnostics Market is expected to reach a 50.21 USD Million by 2032 and is projected to grow at a CAGR of 9.81% from 2025 to 2032.

Revenue, 2024 (USD Million)
27.54
Forecast, 2032 (USD Million)
50.21
CAGR, 2024 - 2032
9.81%
Report Coverage
U.K.

U.K. PCR-Based Transplant Diagnostics Market 2018-2032 USD Million

U.K. PCR-Based Transplant Diagnostics Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 27.54 USD Million
  • Projected Market Size (2032): 50.21 USD Million
  • CAGR (2025-2032): 9.81%

Key Findings of U.K. PCR-Based Transplant Diagnostics Market

  • The U.K. PCR-Based Transplant Diagnostics Market was valued at 27.54 USD Million in 2024.
  • The U.K. PCR-Based Transplant Diagnostics Market is likely to grow at a CAGR of 9.81% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Diagnostic Applications in Application Segment accounted for the largest share of the market with a revenue of 26.57 USD Million
  • The fastest growing segment CMV PCR Test in Test Segment grew Fastest with a CAGR of 11.41% during the forecast period from 2024 to 2032.

U.K. PCR-Based Transplant Diagnostics Market Scope

U.K. PCR-Based Transplant Diagnostics Market Segmentation & Scope
End User
  • Research Laboratories and Academic Institutes
  • Commercial Service Providers
  • Hospitals and Transplant Centers
Application
  • Research Applications
  • Diagnostic Applications
Transplant Type
  • Other Transplantations
  • Pancreas Transplantation
  • Lung Transplantation
  • Heart Transplantation
  • Liver Transplantation
  • Kidney Transplantation
Test
  • Aspergillus Spp PCR Test
  • Adenovirus PCR Test
  • JCV PCR Test
  • P. Jirovecii PCR Test
  • Parvovirus B19 PCR Test
  • HSV2 PCR Test
  • HSV1 PCR Test
  • VZV PCR Test
  • BKV PCR Test
  • EBV PCR Test
  • CMV PCR Test

U.K. PCR-Based Transplant Diagnostics Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Million
Market Value in 2024 27.54 USD Million
Market Value in 2032 50.21 USD Million
CAGR (2025-2032) 9.81%
Historic Data 2016-2023
Market Segments Covered End User,Application,Transplant Type,Test

Regional Insights:

  • Leading Market (2024-2032): U.K., leading in terms of revenue 27.54 USD Million in 2024
    • Key Country: U.K., leading in terms of revenue with value of 27.54 USD Million in 2024.

Segments and Scope

  • U.K. PCR-Based Transplant Diagnostics Market to 2032, By End User
    • Hospitals and Transplant Centers is the largest segment in U.K. PCR-Based Transplant Diagnostics Market to 2032 with a revenue of 21.59 USD Million in the year 2024.
    • Hospitals and Transplant Centers is the Fastest growing segment in U.K. PCR-Based Transplant Diagnostics Market to 2032 with a Growth rate of 10.03 % in forecast period 2025-2032.
  • U.K. PCR-Based Transplant Diagnostics Market to 2032, By Application
    • Diagnostic Applications is the largest segment in U.K. PCR-Based Transplant Diagnostics Market to 2032 with a revenue of 26.57 USD Million in the year 2024.
    • Diagnostic Applications is the Fastest growing segment in U.K. PCR-Based Transplant Diagnostics Market to 2032 with a Growth rate of 9.98 % in forecast period 2025-2032.
  • U.K. PCR-Based Transplant Diagnostics Market to 2032, By Transplant Type
    • Kidney Transplantation is the largest segment in U.K. PCR-Based Transplant Diagnostics Market to 2032 with a revenue of 17.99 USD Million in the year 2024.
    • Kidney Transplantation is the Fastest growing segment in U.K. PCR-Based Transplant Diagnostics Market to 2032 with a Growth rate of 10.15 % in forecast period 2025-2032.
  • U.K. PCR-Based Transplant Diagnostics Market to 2032, By Test
    • CMV PCR Test is the largest segment in U.K. PCR-Based Transplant Diagnostics Market to 2032 with a revenue of 12.51 USD Million in the year 2024.
    • CMV PCR Test is the Fastest growing segment in U.K. PCR-Based Transplant Diagnostics Market to 2032 with a Growth rate of 11.41 % in forecast period 2025-2032.

U.K. PCR-Based Transplant Diagnostics Market Company Share Analysis

 
U.K. PCR-Based Transplant Diagnostics Market Company Share Analysis
U.K. PCR-Based Transplant Diagnostics Market Company Share Analysis

U.K. PCR-Based Transplant Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. PCR-Based Transplant Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. PCR-Based Transplant Diagnostics Market Company Profiling

U.K. PCR-Based Transplant Diagnostics Market Company Profiling
Frequently Asked Questions
The U.K. PCR-Based Transplant Diagnostics Market is segmented based on Segmentation End User,Application,Transplant Type,Test.
U.K. PCR-Based Transplant Diagnostics Market was valued at USD 27.54(Revenue in USD Million) in 2022.
U.K. PCR-Based Transplant Diagnostics Market is projected to grow at a CAGR of 9.81% during the forecast period of 2024 to 2032.
The Diagnostic Applications segment is expected to dominate the U.K. PCR-Based Transplant Diagnostics Market, holding a largest market share of 26.57 USD Million in 2024

U.K. PCR-Based Transplant Diagnostics Market Scope

U.K. PCR-Based Transplant Diagnostics Market Segmentation & Scope
End User
  • Research Laboratories and Academic Institutes
  • Commercial Service Providers
  • Hospitals and Transplant Centers
Application
  • Research Applications
  • Diagnostic Applications
Transplant Type
  • Other Transplantations
  • Pancreas Transplantation
  • Lung Transplantation
  • Heart Transplantation
  • Liver Transplantation
  • Kidney Transplantation
Test
  • Aspergillus Spp PCR Test
  • Adenovirus PCR Test
  • JCV PCR Test
  • P. Jirovecii PCR Test
  • Parvovirus B19 PCR Test
  • HSV2 PCR Test
  • HSV1 PCR Test
  • VZV PCR Test
  • BKV PCR Test
  • EBV PCR Test
  • CMV PCR Test
Frequently Asked Questions
The U.K. PCR-Based Transplant Diagnostics Market is segmented based on Segmentation End User,Application,Transplant Type,Test.
U.K. PCR-Based Transplant Diagnostics Market was valued at USD 27.54(Revenue in USD Million) in 2022.
U.K. PCR-Based Transplant Diagnostics Market is projected to grow at a CAGR of 9.81% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. PCR-Based Transplant Diagnostics Market for final year is USD 50.21 (USD Million).

U.K. PCR-Based Transplant Diagnostics Market Company Profiling

U.K. PCR-Based Transplant Diagnostics Market Company Profiling
Frequently Asked Questions
The U.K. PCR-Based Transplant Diagnostics Market is segmented based on Segmentation End User,Application,Transplant Type,Test.
U.K. PCR-Based Transplant Diagnostics Market was valued at USD 27.54(Revenue in USD Million) in 2022.
U.K. PCR-Based Transplant Diagnostics Market is projected to grow at a CAGR of 9.81% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. PCR-Based Transplant Diagnostics Market for final year is USD 50.21 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.